Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Change in Receivables (2018 - 2025)

AVITA Medical filings provide 8 years of Change in Receivables readings, the most recent being -$81000.0 for Q4 2025.

  • On a quarterly basis, Change in Receivables rose 94.56% to -$81000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $3.6 million, a 187.65% increase, with the full-year FY2025 number at $3.6 million, up 187.65% from a year prior.
  • Change in Receivables hit -$81000.0 in Q4 2025 for AVITA Medical, down from $2.3 million in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $3.5 million in Q2 2021 to a low of -$3.5 million in Q4 2023.
  • Median Change in Receivables over the past 5 years was -$241000.0 (2023), compared with a mean of -$130411.8.
  • The widest YoY moves for Change in Receivables: up 333.64% in 2021, down 22320.0% in 2021.
  • AVITA Medical's Change in Receivables stood at -$3.3 million in 2021, then soared by 73.63% to -$879000.0 in 2022, then tumbled by 295.34% to -$3.5 million in 2023, then surged by 57.15% to -$1.5 million in 2024, then skyrocketed by 94.56% to -$81000.0 in 2025.
  • The last three reported values for Change in Receivables were -$81000.0 (Q4 2025), $2.3 million (Q3 2025), and $1.6 million (Q2 2025) per Business Quant data.